Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Esophageal Strictures-I: Introduction01:30

Esophageal Strictures-I: Introduction

112
Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
112
Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

104
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
104
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

168
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
168
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

78
Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
78
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

93
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
93
Esophagus01:24

Esophagus

955
The esophagus, a muscular conduit linking the pharynx and stomach, measures roughly 10 inches (25.4 cm) and sits behind the trachea. It remains collapsed when not swallowing. The esophagus follows a predominantly straight path through the thoracic mediastinum and enters the abdominal cavity through a diaphragmatic opening known as the esophageal hiatus.
The movement of edibles from the pharynx into the esophagus is facilitated by the upper esophageal sphincter, which is formed primarily by the...
955

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Role of Microbiota and Fecal Transplantation in Inflammatory Bowel Disease.

Pathogens (Basel, Switzerland)·2026
Same author

Integrating Intestinal Ultrasound in the Personalized Management of IBD.

Journal of personalized medicine·2026
Same author

Novel insights into autoimmune gastritis: clinical profile and gastric neoplastic risk from an international multicentre study.

Gut·2026
Same author

Perianal Crohn's Disease in Inflammatory Bowel Disease: Diagnosis, Assessment and Treatment.

Life (Basel, Switzerland)·2026
Same author

Unmasking a New Trauma in Inflammatory Bowel Disease: Unequal Psychological Burden.

Inflammatory bowel diseases·2025
Same author

The intratumor microbiome and cancer immunity: from pathogenesis to therapeutic opportunities through artificial intelligence.

Expert review of clinical immunology·2025

Related Experiment Video

Updated: Jul 12, 2025

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
03:23

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis

Published on: May 10, 2024

799

Eosinophilic esophagitis: does age matter?

Sara Massironi1,2, Alessandra Elvevi1, Roberto Panceri3

  • 1Division of Gastroenterology, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italia.

Expert Review of Clinical Immunology
|October 23, 2023
PubMed
Summary
This summary is machine-generated.

Eosinophilic esophagitis (EoE) is a growing esophageal condition. This review highlights EoE diagnosis and treatment in adults and children, emphasizing age-specific care for optimal outcomes.

Keywords:
AdultDupilumabEosinophilic esophagitischildrenfood impaction

More Related Videos

Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation
10:15

Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation

Published on: March 22, 2017

7.0K
Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

465

Related Experiment Videos

Last Updated: Jul 12, 2025

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
03:23

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis

Published on: May 10, 2024

799
Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation
10:15

Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation

Published on: March 22, 2017

7.0K
Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

465

Area of Science:

  • Gastroenterology
  • Immunology
  • Pediatrics

Background:

  • Eosinophilic esophagitis (EoE) is a chronic, increasingly prevalent esophageal inflammatory disease.
  • EoE is multifactorial, involving immunologic, genetic, and environmental factors.
  • Clinical presentation and management differ between pediatric and adult populations.

Purpose of the Study:

  • To provide an overview of the current state of EoE epidemiology, diagnosis, and treatment.
  • To focus on the similarities and differences in EoE management between adults and children.
  • To identify areas for future research and clinical advancement.

Main Methods:

  • A comprehensive literature search was conducted in PubMed/MEDLINE, EMBASE, and SCOPUS.
  • Studies published between January 2010 and January 2023 were included.
  • The review focused on epidemiological data, diagnostic criteria, and therapeutic approaches.

Main Results:

  • Significant progress has been made in understanding EoE.
  • Key differences exist in treatment strategies, particularly concerning pediatric growth.
  • Close monitoring is crucial for pediatric patients to prevent growth disturbances.

Conclusions:

  • Further research is needed to optimize diagnostic strategies and tailored treatment for EoE.
  • Advances in monitoring and follow-up are essential for improving long-term patient outcomes.
  • Precision medicine approaches promise more tailored and effective EoE management.